Background Image
Previous Page  44 / 88 Next Page
Information
Show Menu
Previous Page 44 / 88 Next Page
Page Background

40

New Biological Frontiers Illuminated by Molecular Sensors and Actuators

Poster Abstracts

5-POS

Board 5

Genetically Encoded Tools to Manipulate and Observe Cellular Dynamics in Cardiac

Disease Modelling and Drug Screening

Yu-Fen Chang

, Frances Book, Mark J. Davies, Matthew J. Daniels.

University of Oxford, Oxford, United Kingdom.

Optogenetic technology allows us to control depolarization of electrically excitable cells using

ion-channels that open in response to light. Genetically Encoded Calcium Indicators (GECIs) can

be utilized to visualize cellular response upon opto-stimulation in real time. Previously, we have

successfully demonstrated the use of channelrhodopsin2 (ChR2), a light sensitive cation channel,

with a spectrally compatible red shifted calcium indicator (R-GECO) in a transient expressing

neuronal model. Here, we presented a viral delivery system for the two component parts (an

improved ChR2 and R-GECO) required to target relevant cardiac substrates such as adult guinea

pig cardiomyocytes human-embryonic-stem-cell derived cardiomyocytes (hES-CM), and patient

derived iPS cardiomyocyte derivatives allowing light stimulation with simultaneous Ca++

imaging. To prove the concept of contactless drug screening in excitable cells, known small

molecules were tested on hES-CMs in multi-well plates. Increased Ca++ influx was observed in

hES-CMs upon blue light stimulation after treatment of BayK8644, the L-Type Ca++ channel

agonist. On the other hand, cytosolic calcium fell upon light activation after treating with

BAPTA, a Ca++ chelator. The contactless nature of this technology enables high-throughput

drug screening to be targeted to rapid and reversible phenomena like Ca++ handling, providing a

new platform for cardiac disease modelling.